GIMBHI’s daily mental health update — 12/16/25

💰 Ritten raises $35M to expand AI behavioral health platform (John George, Philadelphia Business Journal) — 12/12/25
TL;DR: Philadelphia startup Ritten raised $35M to grow tools that reduce burnout and improve behavioral health operations.

🧩 Radial Health raises $50M to expand mental health clinics nationwide (Amanda D’Ambrosio, Crain’s New York Business) — 12/12/25
TL;DR: Radial Health raised $50M to grow its clinics offering electromagnetic therapy and fast-acting mental health treatments.

🧬 Punto Health raises €2.3M to expand AI dementia care platform (Rahul Raj, EU-Startups) — 12/11/25
TL;DR: London-based Punto Health raised €2.3M to scale AI tools for early detection and ongoing dementia care in Europe.

🧠 Subsense raises additional $10M for non-surgical brain–computer interface (Danny Sullivan, Longevity.Technology) — 12/11/25
TL;DR: Subsense brought total funding to $27M to advance nanoparticle-based brain–computer interfaces without surgery.

🏥 Bridgeway launches $2M campaign to expand outpatient mental health services (Bridgeway Behavioral Health Services, PR Newswire) — 12/10/25
TL;DR: Bridgeway began a $2M campaign to renovate and expand an outpatient mental health center in Union County, New Jersey.

🏙️ NYC Health + Hospitals deploys $32M mental health outreach teams (Amanda D’Ambrosio, Crain’s New York Business) — 12/11/25
TL;DR: NYC’s public hospital system launched outreach teams to help patients stay out of ERs and psychiatric units.

🌐 Kentucky adopts tech, telehealth, and new care models for mental health (Dawn Marie Yankeelov, The Lane Report) — 12/11/25
TL;DR: Kentucky is testing new care models, telehealth, and tech tools to address rising mental health needs statewide.

🤝 Holly Health partners with Patient.info to offer digital health coaching (Tammy Lovell, Digital Health) — 12/15/25
TL;DR: Holly Health’s digital coaching is now available on Patient.info, used by over 200 GP practices in the UK.

🏠 FDA approves first at-home, non-drug device for depression care (Conor Hale, Fierce MedTech) — 12/11/25
TL;DR: FDA cleared a wearable brain stimulation headset for treating moderate to severe depression at home.

Subscribe to news and reports about mental health startups & mental health investors at gimbhi.substack.com